FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elaine Hylek

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Alok Kapoor; Jeffrey N Katz; Rebecca A Silliman; Howard Cabral; Priscilla Chew; Elaine M Hylek; Dan Berlowitz
Venous thromboembolism after joint replacement in older male veterans with comorbidity.
Elaine M Hylek
Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement.
G Guyatt; E Akl; M Crowther; John W Eikelboom; C Francis; D Garcia; M Gould; Elaine M Hylek; S Kahn; R Kunz; D Quinlan; P Vandvik; Jack Hirsh
A response to - There's madness in their methods.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elaine Hylek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alok Kapoor; Jeffrey N Katz; Rebecca A Silliman; Howard Cabral; Priscilla Chew; Elaine M Hylek; Dan Berlowitz
Venous thromboembolism after joint replacement in older male veterans with comorbidity.
Journal of the American Geriatrics Society 2013;61(4):590-601.
2013: Elaine M Hylek
Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement.
Journal of thrombosis and thrombolysis 2013;35(3):333-5.
2013: G Guyatt; E Akl; M Crowther; John W Eikelboom; C Francis; D Garcia; M Gould; Elaine M Hylek; S Kahn; R Kunz; D Quinlan; P Vandvik; Jack Hirsh
A response to - There's madness in their methods.
Journal of thrombosis and haemostasis : JTH 2013;11(4):785-6.
2013: Elaine M Hylek
Anticoagulation therapy for atrial fibrillation.
Seminars in thrombosis and hemostasis 2013;39(2):147-52.
2013: Adam J Rose; Shibei Zhao; Arlene S Ash; Dan R Berlowitz; Donald R Miller; Al Ozonoff; Joel I Reisman; Elaine M Hylek
Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence.
Chest 2013;143(3):751-7.
2013: Amresh D Hanchate; Wei Huang; lee schwamm; Elaine M Hylek
Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status.
Stroke; a journal of cerebral circulation 2013;44(2):469-76.
2013: Guneet K Jasuja; Donald R Miller; Al Ozonoff; Joel I Reisman; Arlene S Ash; Dan R Berlowitz; Elaine M Hylek; Shibei Zhao; Adam J Rose
Identifying major hemorrhage with automated data: results of the veterans affairs study to improve anticoagulation (VARIA).
Thrombosis research 2013;131(1):31-6.
2012: Renato D Lopes; John J V McMurray; Puneet Mohan; Dragos Vinereanu; Lars Wallentin; Hongqiu Yang; Sana M Al-Khatib; Jack Ansell; M Cecilia Bahit; Raffaele De Caterina; Paul Dorian; J Donald Easton; Cetin Erol; Justin A Ezekowitz; Bernard J Gersh; Christopher B Granger; Stefan H Hohnloser; John Horowitz; Elaine M Hylek; John H Alexander
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lancet 2012;380(9855):1749-58.
2012: Daniel M Witt; Walter Ageno; Nathan P Clark; Thomas Delate; Francesco Dentali; David A Garcia; Elaine M Hylek; Mark A Crowther
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Archives of internal medicine 2012;172(19):1484-91.
2012: Mark A Hlatky; Elaine M Hylek; Emelia J Benjamin; Nakela L Cook; Kay Dickersin; Pamela S Douglas; David C Goff; Alan T Hirsch; Eric D Peterson; Véronique L Roger; Joseph V Selby; James E Udelson; Barbara Wells; Michael S Lauer
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
Journal of the American College of Cardiology 2012;60(7):569-80.
2012: Adam J Rose; Patricia Callahan; Elaine M Hylek; Scott Mambourg; Dimple Patel; Beth Ann Petrakis; Barbara G Bokhour
Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration.
Health services research 2012;47(4):1541-60.
2012: Renato D Lopes; L Kristin Newby; Eric D Peterson; Jorge Pinto Ribeiro; Ana Thereza Rocha; Tracy Wang; Roberto R Giraldez; Christopher B Granger; Robert A Harrington; Elaine M Hylek; Renato A K Kalil; Antonio C Lopes; Jadelson Andrade; Marianna Andrande; Richard C Becker; Otavio Berwanger; Fabio Villas Boas; Antonio C Carvalho; Mark Crowther; Eduardo Darze; Gilson Soares Feitosa; David A Garcia
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.
Journal of thrombosis and thrombolysis 2012;34(1):143-63.
2012: A J Rose; S Zhao; Dan R Berlowitz; Elaine M Hylek; Donald R Miller; A Ozonoff; J I Reisman; Arlene S Ash
INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
Journal of thrombosis and haemostasis : JTH 2012;10(4):590-5.
2012: John J You; Mark H Eckman; Margaret C Fang; Alan S Go; Jonathan L Halperin; Patricia A Howard; Michael Hughes; Elaine M Hylek; Deirdre A Lane; Gregory Y H Lip; Warren J Manning; Sam Schulman; Daniel E Singer; Frederick A Spencer
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e531S-75S.
2012: Walter Ageno; Mark Crowther; Alexander S Gallus; Elaine M Hylek; Gualtiero Palareti; Ann Wittkowsky
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest 2012;141(2 Suppl):e44S-88S.
2011: Jonathan P Piccini; Laine E Thomas; Jack E Ansell; Gregg C Fonarow; Elizabeth S Fraulo; Bernard J Gersh; Alan S Go; Elaine M Hylek; Melissa H Kong; Peter R Kowey; Renato D Lopes; Kenneth W Mahaffey; Roger M Mills; Eric D Peterson
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
American heart journal 2011;162(4):606-612.e1.
2011: Raffaele De Caterina; Elaine M Hylek
Stroke prevention in atrial fibrillation: current status and near-future directions.
The American journal of medicine 2011;124(9):793-9.
2011: Renato D Lopes; Kenneth W Mahaffey; Helena B Nader; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; John H Alexander; Paul W Armstrong; Richard C Becker; Joyce M A Bizzachi; Robert M Califf; Antonio C Carvalho; Mark Y Chan; Mark Crowther; Roberto R Giraldez; Christopher B Granger; Helio P Guimaraes; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Renato A K Kalil; Antonio C Lopes; David A Garcia
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
Journal of thrombosis and thrombolysis 2011;32(2):242-66.
2011: Adam J Rose; Arlene S Ash; Dan R Berlowitz; Al Ozonoff; Joel I Reisman; Elaine M Hylek
Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation.
Chest 2011;140(2):359-65.
2011: Adam J Rose; Arlene S Ash; Dan R Berlowitz; Elaine M Hylek; Al Ozonoff; Jeremy D Goldhaber-Fiebert
The business case for quality improvement: oral anticoagulation for atrial fibrillation.
Circulation. Cardiovascular quality and outcomes 2011;4(4):416-24.
2011: Adam J Rose; Elaine M Hylek; Dan R Berlowitz; Arlene S Ash; Joel I Reisman; Al Ozonoff
Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
Circulation. Cardiovascular quality and outcomes 2011;4(3):276-82.
2011: Adam J Rose; Elaine M Hylek; Al Ozonoff; Arlene S Ash; Joel I Reisman; Patricia P Callahan; Margaret M Gordon; Dan R Berlowitz
Relevance of current guidelines for organizing an anticoagulation clinic.
The American journal of managed care 2011;17(4):284-9.
2011: Adam J Rose; Elaine M Hylek; Al Ozonoff; Arlene S Ash; Joel I Reisman; Dan R Berlowitz
Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).
Circulation. Cardiovascular quality and outcomes 2011;4(1):22-9.
2010: Elaine M Hylek
Therapeutic potential of oral factor Xa inhibitors.
The New England journal of medicine 2010;363(26):2559-61.
2010: David A Garcia; Renato D Lopes; Elaine M Hylek
New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
Thrombosis and haemostasis 2010;104(6):1099-105.
2010: Adam J Rose; Elaine M Hylek
High blood pressure while taking antithrombotic medication is associated with an increased risk of developing intracranial haemorrhage.
Evidence-based medicine 2010;15(6):189-90.
2010: A J Rose; Elaine M Hylek; A Ozonoff; Arlene S Ash; J I Reisman; D R Berlowitz
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
Journal of thrombosis and haemostasis : JTH 2010;8(10):2182-91.
2010: D M Witt; Thomas Delate; N P Clark; C Martell; T Tran; M A Crowther; D A Garcia; W Ageno; Elaine M Hylek
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
Journal of thrombosis and haemostasis : JTH 2010;8(4):744-9.
2010: Andrew Cowan; Elaine M Hylek
Bleeding risk on warfarin among elderly patients with atrial fibrillation.
Journal of the American College of Cardiology 2010;55(9):932; author reply 932-3.
2010: Renato D Lopes; John H Alexander; Sana M Al-Khatib; Jack Ansell; Raphael Diaz; J Donald Easton; Bernard J Gersh; Christopher B Granger; Michael Hanna; John Horowitz; Elaine M Hylek; John J V McMurray; Freek W A Verheugt; Lars Wallentin
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
American heart journal 2010;159(3):331-9.
2009: Adam J Rose; Al Ozonoff; Richard W Grant; Lori E Henault; Elaine M Hylek
Epidemiology of subtherapeutic anticoagulation in the United States.
Circulation. Cardiovascular quality and outcomes 2009;2(6):591-7.
2009: Elaine M Hylek
Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
Seminars in thrombosis and hemostasis 2009;35(6):548-53.
2009: Elaine M Hylek
The need for new oral anticoagulants in clinical practice.
Journal of cardiovascular medicine (Hagerstown, Md.) 2009;10(8):605-9.
2009: Daniel M Witt; Thomas Delate; Nathan P Clark; Chad Martell; Thu Tran; Mark A Crowther; David A Garcia; Walter Ageno; Elaine M Hylek
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.
Blood 2009;114(5):952-6.
2009: Renato D Lopes; Richard C Becker; David Garcia; Elaine M Hylek; Christopher B Granger; Dayse M Lourenço; Helena B Nader; Francisco H A Maffei; Fernando Cesena; José C Nicolau; Ari Timmerman; Ana T Rocha; Edison F de Paiva; Helio P Guimaraes; Antonio C Carvalho; Elbio A D'Amico; Carlos A Moreira-Filho; José M Aldrighi; Antonio C Lopes
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil.
Journal of thrombosis and thrombolysis 2009;28(1):106-16.
2009: Adam J Rose; Dan R Berlowitz; Susan M Frayne; Elaine M Hylek
Measuring quality of oral anticoagulation care: extending quality measurement to a new field.
Joint Commission journal on quality and patient safety / Joint Commission Resources 2009;35(3):146-55.
2009: Elaine M Hylek; Adam J Rose
Understanding low INR in clinical practice.
Thrombosis and haemostasis 2009;101(3):417-8.
2009: Jane E Freedman; Elaine M Hylek
Clopidogrel, genetics, and drug responsiveness.
The New England journal of medicine 2009;360(4):411-3.
2008: Renato D Lopes; Jonathan P Piccini; Elaine M Hylek; Christopher B Granger; John H Alexander
Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.
Journal of thrombosis and thrombolysis 2008;26(3):167-74.
2008: Elaine M Hylek; Lars Frison; Lori E Henault; Adrienne Cupples
Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.
Stroke; a journal of cerebral circulation 2008;39(11):3009-14.
2008: Nathan P Clark; Daniel M Witt; Thomas Delate; Melissa Trapp; David Garcia; Walter Ageno; Elaine M Hylek; Mark A Crowther
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Pharmacotherapy 2008;28(8):960-7.
2008: Elaine M Hylek
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Thrombosis and haemostasis 2008;100(1):16-7.
2008: David A Garcia; Daniel M Witt; Elaine M Hylek; Ann K Wittkowsky; Edith A Nutescu; Alan Jacobson; Stephan Moll; Geno J Merli; Mark Crowther; Laura Earl; Richard C Becker; Lynn Oertel; Amir K Jaffer; Jack E Ansell
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
The Annals of pharmacotherapy 2008;42(7):979-88.
2008: Jack Ansell; Jack Hirsh; Elaine M Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):160S-198S.
2008: Reshma Jagsi; Nancy J Tarbell; Lori E Henault; Yuchiao Chang; Elaine M Hylek
The representation of women on the editorial boards of major medical journals: a 35-year perspective.
Archives of internal medicine 2008;168(5):544-8.
2008: Elaine M Hylek; David E Solarz
Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination.
JACC. Cardiovascular interventions 2008;1(1):62-4.
2008: Henry I Bussey; Ann K Wittkowsky; Elaine M Hylek; Marie B Walker
Genetic testing for warfarin dosing? Not yet ready for prime time.
Pharmacotherapy 2008;28(2):141-3.
2008: David A Garcia; Susan Regan; Lori E Henault; Ashish Upadhyay; Jaclyn Baker; Mohamed Othman; Elaine M Hylek
Risk of thromboembolism with short-term interruption of warfarin therapy.
Archives of internal medicine 2008;168(1):63-9.
2008: Elaine M Hylek
Oral anticoagulant therapy for patients with atrial fibrillation--an update.
Thrombosis research 2008;123 Suppl 1():S46-9.
2008: Elaine M Hylek; Jared W Magnani
Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(1):3-5.
2007: Elaine M Hylek
DU-176b, an oral, direct Factor Xa antagonist.
Current opinion in investigational drugs (London, England : 2000) 2007;8(9):778-83.
2007: David Garcia; Elaine M Hylek
Stroke prevention in elderly patients with atrial fibrillation.
Lancet 2007;370(9586):460-1.
2007: Margaret C Fang; Alan S Go; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Daniel E Singer
Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
The American journal of medicine 2007;120(8):700-5.
2007: Carmella Evans-Molina; Susan Regan; Lori E Henault; Elaine M Hylek; Gregory R Schwartz
The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
Journal of the American Geriatrics Society 2007;55(7):1038-43.
2007: Adam J Rose; Jeff P Sharman; Al Ozonoff; Lori E Henault; Elaine M Hylek
Effectiveness of warfarin among patients with cancer.
Journal of general internal medicine 2007;22(7):997-1002.
2007: Elaine M Hylek; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Circulation 2007;115(21):2689-96.
2007: David Garcia; Elaine M Hylek
A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
Evidence-based medicine 2007;12(2):57.
2007: Elaine M Hylek
Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?
Nature clinical practice. Cardiovascular medicine 2007;4(4):186-7.
2007: David Garcia; Elaine M Hylek
A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
ACP journal club 2007;146(2):52.
2006: Margaret C Fang; Alan S Go; Elaine M Hylek; Yuchiao Chang; Lori E Henault; Nancy G Jensvold; Daniel E Singer
Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
Journal of the American Geriatrics Society 2006;54(8):1231-6.
2006: Reshma Jagsi; Elizabeth A Guancial; Cynthia Cooper Worobey; Lori E Henault; Yuchiao Chang; Rebecca Starr; Nancy J Tarbell; Elaine M Hylek
The "gender gap" in authorship of academic medical literature--a 35-year perspective.
The New England journal of medicine 2006;355(3):281-7.
2006: Elaine M Hylek; James D'Antonio; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.
Stroke; a journal of cerebral circulation 2006;37(4):1075-80.
2006: David A Garcia; Susan Regan; Mark Crowther; Elaine M Hylek
The risk of hemorrhage among patients with warfarin-associated coagulopathy.
Journal of the American College of Cardiology 2006;47(4):804-8.
2006: David A Garcia; Elaine M Hylek
Antithrombotic therapy in atrial fibrillation.
Clinics in geriatric medicine 2006;22(1):155-66, x.
2006: Gordon Guyatt; David Gutterman; Michael H Baumann; Doreen J Addrizzo-Harris; Elaine M Hylek; Barbara Phillips; Gary E Raskob; Sandra Zelman Lewis; Holger J Schünemann
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.
Chest 2006;129(1):174-81.
2005: Margaret C Fang; Daniel E Singer; Yuchiao Chang; Elaine M Hylek; Lori E Henault; Nancy G Jensvold; Alan S Go
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.
Circulation 2005;112(12):1687-91.
2005: David Garcia; Susan Regan; Mark Crowther; Robert A Hughes; Elaine M Hylek
Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.
Chest 2005;127(6):2049-56.
2004: Margaret C Fang; Yuchiao Chang; Elaine M Hylek; Jonathan Rosand; Steven M Greenberg; Alan S Go; Daniel E Singer
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Annals of internal medicine 2004;141(10):745-52.
2004: Elaine M Hylek
Paracetamol (acetaminophen) and warfarin interaction: unraveling the pivotal role of the vitamin K cycle.
Thrombosis and haemostasis 2004;92(4):672-3.
2004: Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine M Hylek
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):204S-233S.
2003: Alan S Go; Elaine M Hylek; Yuchiao Chang; Kathleen A Phillips; Lori E Henault; Angela M Capra; Nancy G Jensvold; Joe V Selby; Daniel E Singer
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
JAMA : the journal of the American Medical Association 2003;290(20):2685-92.
2003: Elaine M Hylek; Alan S Go; Yuchiao Chang; Nancy G Jensvold; Lori E Henault; Joe V Selby; Daniel E Singer
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
The New England journal of medicine 2003;349(11):1019-26.
2003: Elaine M Hylek
Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
Seminars in vascular medicine 2003;3(3):271-8.
2003: Elaine M Hylek
Trends in anticoagulation management across community-based practices in the United States: the Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) study.
Journal of thrombosis and thrombolysis 2003;16(1-2):83-6.
2003: Elaine M Hylek; Susan Regan; Lori E Henault; Margaret Gardner; Andrew T Chan; Daniel E Singer; Michael J Barry
Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.
Archives of internal medicine 2003;163(5):621-7.
2003: Alan S Go; Guy L Reed; Elaine M Hylek; Kathleen A Phillips; Lin Liu; Lori E Henault; Joe V Selby; Daniel E Singer
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Journal of thrombosis and thrombolysis 2003;15(1):41-6.
2002: Eric E Smith; Jonathan Rosand; Katherine A Knudsen; Elaine M Hylek; Steven M Greenberg
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.
Neurology 2002;59(2):193-7.
2001: Elaine M Hylek; Susan Regan; Alan S Go; R A Hughes; Daniel E Singer; Steven J Skates
Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
Annals of internal medicine 2001;135(6):393-400.
2001: Alan S Go; Elaine M Hylek; Kathleen A Phillips; Yuchiao Chang; Lori E Henault; Joe V Selby; Daniel E Singer
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
JAMA : the journal of the American Medical Association 2001;285(18):2370-5.
2001: Elaine M Hylek
Oral anticoagulants. Pharmacologic issues for use in the elderly.
Clinics in geriatric medicine 2001;17(1):1-13.
2000: Jonathan Rosand; Elaine M Hylek; HC O'Donnell; Steven M Greenberg
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.
Neurology 2000;55(7):947-51.
2000: Alan S Go; Elaine M Hylek; Kathleen A Phillips; LH Borowsky; Lori E Henault; Yuchiao Chang; Joe V Selby; Daniel E Singer
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
Circulation 2000;102(1):11-3.
2000: Elaine M Hylek; Y C Chang; Steven J Skates; R A Hughes; Daniel E Singer
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
Archives of internal medicine 2000;160(11):1612-7.
1999: Alan S Go; Elaine M Hylek; LH Borowsky; Kathleen A Phillips; Joe V Selby; Daniel E Singer
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
Annals of internal medicine 1999;131(12):927-34.
1998: Elaine M Hylek; H Heiman; Steven J Skates; M A Sheehan; Daniel E Singer
Acetaminophen and other risk factors for excessive warfarin anticoagulation.
JAMA : the journal of the American Medical Association 1998;279(9):657-62.
1996: Elaine M Hylek; Steven J Skates; M A Sheehan; Daniel E Singer
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
The New England journal of medicine 1996;335(8):540-6.
1995: Daniel E Singer; Elaine M Hylek
Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
The New England journal of medicine 1995;333(22):1504.
1994: Elaine M Hylek; Daniel E Singer
Risk factors for intracranial hemorrhage in outpatients taking warfarin.
Annals of internal medicine 1994;120(11):897-902.